Literature DB >> 10077646

Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.

P S Nelson1, L Gan, C Ferguson, P Moss, R Gelinas, L Hood, K Wang.   

Abstract

The identification of genes with selective expression in specific organs or cell types provides an entry point for understanding biological processes that occur uniquely within a particular tissue. Using a subtraction approach designed to identify genes preferentially expressed in specific tissues, we have identified prostase, a human serine protease with prostate-restricted expression. The prostase cDNA encodes a putative 254-aa polypeptide with a conserved serine protease catalytic triad and an amino-terminal pre-propeptide sequence, indicating a potential secretory function. The genomic sequence comprises five exons and four introns and contains multiple copies of a chromosome 19q-specific minisatellite repeat. Northern analysis indicates that prostase mRNA is expressed in hormonally responsive normal and neoplastic prostate epithelial tissues, but not in prostate stromal constituents. Prostase shares 35% amino acid identity with prostate-specific antigen (PSA) and 78% identity with the porcine enamel matrix serine proteinase 1, an enzyme involved in enamel matrix degradation and with a putative role in the disruption of intercellular junctions. Radiation-hybrid-panel mapping localized prostase to chromosome 19q13, a region containing several other serine proteases, including protease M, pancreatic/renal kallikrein hK1, and the prostate-specific kallikreins hK2 and hK3 (PSA). The sequence homology between prostase and other well-characterized serine proteases suggests several potential functional roles for the prostase protein that include the degradation of extracellular matrix and the activation of PSA and other proteases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077646      PMCID: PMC15904          DOI: 10.1073/pnas.96.6.3114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.

Authors:  P Correale; K Walmsley; C Nieroda; S Zaremba; M Zhu; J Schlom; K Y Tsang
Journal:  J Natl Cancer Inst       Date:  1997-02-19       Impact factor: 13.506

2.  Prediction of probable genes by Fourier analysis of genomic sequences.

Authors:  S Tiwari; S Ramachandran; A Bhattacharya; S Bhattacharya; R Ramaswamy
Journal:  Comput Appl Biosci       Date:  1997-06

3.  Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.

Authors:  H Nielsen; J Engelbrecht; S Brunak; G von Heijne
Journal:  Protein Eng       Date:  1997-01

Review 4.  Gene therapy for prostate cancer.

Authors:  K Sikora; H Pandha
Journal:  Br J Urol       Date:  1997-04

5.  An STS-based radiation hybrid map of the human genome.

Authors:  E A Stewart; K B McKusick; A Aggarwal; E Bajorek; S Brady; A Chu; N Fang; D Hadley; M Harris; S Hussain; R Lee; A Maratukulam; K O'Connor; S Perkins; M Piercy; F Qin; T Reif; C Sanders; X She; W L Sun; P Tabar; S Voyticky; S Cowles; J B Fan; C Mader; J Quackenbush; R M Myers; D R Cox
Journal:  Genome Res       Date:  1997-05       Impact factor: 9.043

6.  Prediction of complete gene structures in human genomic DNA.

Authors:  C Burge; S Karlin
Journal:  J Mol Biol       Date:  1997-04-25       Impact factor: 5.469

7.  A novel protease homolog differentially expressed in breast and ovarian cancer.

Authors:  A Anisowicz; G Sotiropoulou; G Stenman; S C Mok; R Sager
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

8.  National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening.

Authors:  A Farkas; D Schneider; M Perrotti; K B Cummings; W S Ward
Journal:  Urology       Date:  1998-09       Impact factor: 2.649

9.  Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.

Authors:  A Bjartell; J Malm; C Moller; M Gunnarsson; A Lundwall
Journal:  J Androl       Date:  1996 Jan-Feb

10.  Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts.

Authors:  S D Cramer; Z Chen; D M Peehl
Journal:  J Urol       Date:  1996-08       Impact factor: 7.450

View more
  29 in total

1.  Prediction of gene function by genome-scale expression analysis: prostate cancer-associated genes.

Authors:  M G Walker; W Volkmuth; E Sprinzak; D Hodgson; T Klingler
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

2.  Activity-based protein profiling: the serine hydrolases.

Authors:  Y Liu; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Expression of kallikrein-related peptidase 4 in dental and non-dental tissues.

Authors:  James P Simmer; Amelia S Richardson; Charles E Smith; Yuanyuan Hu; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

4.  PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer.

Authors:  V Srikantan; Z Zou; G Petrovics; L Xu; M Augustus; L Davis; J R Livezey; T Connell; I A Sesterhenn; K Yoshino; G S Buzard; F K Mostofi; D G McLeod; J W Moul; S Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 5.  Ethnicity and ERG frequency in prostate cancer.

Authors:  Jason Sedarsky; Michael Degon; Shiv Srivastava; Albert Dobi
Journal:  Nat Rev Urol       Date:  2017-09-05       Impact factor: 14.432

6.  Crystal structure of the inhibitor-free form of the serine protease kallikrein-4.

Authors:  Blake T Riley; David E Hoke; Sheena McGowan; Ashley M Buckle
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-07-16       Impact factor: 1.056

7.  A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.

Authors:  John Lai; Melanie L Lehman; Marcel E Dinger; Stephen C Hendy; Tim R Mercer; Inge Seim; Mitchell G Lawrence; John S Mattick; Judith A Clements; Colleen C Nelson
Journal:  RNA       Date:  2010-04-20       Impact factor: 4.942

8.  Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases.

Authors:  Janet C Reid; Admire Matsika; Claire M Davies; Yaowu He; Amy Broomfield; Nigel C Bennett; Viktor Magdolen; Bhuvana Srinivasan; Judith A Clements; John D Hooper
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 9.  Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Authors:  Sarah Gilgunn; Paul J Conroy; Radka Saldova; Pauline M Rudd; Richard J O'Kennedy
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

10.  Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice.

Authors:  James P Simmer; Yuanyuan Hu; Rangsiyakorn Lertlam; Yasuo Yamakoshi; Jan C-C Hu
Journal:  J Biol Chem       Date:  2009-05-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.